Trial intelligence / Profile preview

LB03002 in Children with Growth Hormone Deficiency

NCT00600808Phase 3Completed

Sponsor
BioPartners
Start
Jun 2003
Modality
rProtein (Recombinant Protein), Biologic
01

Overview

A Phase 3 trial of Eutropin Plus in growth hormone deficiency (GHD), sponsored by BioPartners. Started Jun 2003; status: completed.

02

Drugs

Eutropin Plus
03

Conditions

growth hormone deficiency (GHD)

Beyond the preview

Go deeper on NCT00600808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00600808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call